Early breast cancer - optimising treatment for high-risk patients

The management of early breast cancer has evolved immensely over the past few years, particularly in patients with hormone receptor positive (HR+) and HER2 negative (HER2-) cancers. Dr Ronwyn van Eeden tells us more.

Dr Ronwyn van Eeden is a medical oncologist in private practice in Rosebank, Gauteng. She has a special interest in breast cancer, lung cancer, and precision oncology.